Ardent Health, Inc. (NYSE:ARDT - Get Free Report) has been assigned an average recommendation of "Hold" from the fourteen research firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $14.25.
ARDT has been the topic of a number of analyst reports. Mizuho cut their price target on shares of Ardent Health from $20.00 to $12.00 and set an "outperform" rating on the stock in a research report on Thursday, December 18th. Leerink Partners lowered their target price on shares of Ardent Health from $16.00 to $15.00 and set an "outperform" rating for the company in a research note on Friday, March 6th. JPMorgan Chase & Co. cut their target price on shares of Ardent Health from $12.00 to $11.00 and set a "neutral" rating on the stock in a report on Tuesday, January 20th. Royal Bank Of Canada reduced their price target on shares of Ardent Health from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Monday, March 9th. Finally, Zacks Research raised shares of Ardent Health from a "strong sell" rating to a "hold" rating in a report on Wednesday, March 25th.
Read Our Latest Analysis on ARDT
Institutional Investors Weigh In On Ardent Health
Several large investors have recently modified their holdings of the business. Denali Advisors LLC acquired a new position in shares of Ardent Health in the 3rd quarter valued at approximately $2,449,000. SageView Advisory Group LLC raised its holdings in Ardent Health by 367.2% during the 2nd quarter. SageView Advisory Group LLC now owns 790,663 shares of the company's stock worth $10,800,000 after buying an additional 621,430 shares during the period. Pier Capital LLC raised its holdings in Ardent Health by 33.5% during the 3rd quarter. Pier Capital LLC now owns 580,620 shares of the company's stock worth $7,693,000 after buying an additional 145,703 shares during the period. Third Point LLC bought a new position in Ardent Health in the second quarter valued at approximately $1,024,000. Finally, MQS Management LLC bought a new position in Ardent Health in the third quarter valued at approximately $183,000.
Ardent Health Trading Down 0.1%
NYSE ARDT opened at $8.65 on Friday. The stock has a 50-day simple moving average of $9.01 and a 200 day simple moving average of $10.43. The company has a market capitalization of $1.24 billion, a PE ratio of 9.01 and a beta of 0.57. The company has a current ratio of 1.97, a quick ratio of 1.85 and a debt-to-equity ratio of 0.64. Ardent Health has a 12 month low of $8.07 and a 12 month high of $15.48.
Ardent Health (NYSE:ARDT - Get Free Report) last issued its earnings results on Wednesday, March 4th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.35 by ($0.03). The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.63 billion. Ardent Health had a return on equity of 14.30% and a net margin of 2.15%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Research analysts forecast that Ardent Health will post 1.23 EPS for the current year.
About Ardent Health
(
Get Free Report)
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.